Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net loss	$ (115,346)	$ (6,531)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation expense	457	377
Stock-based compensation expense	1,075	781
Change in fair value of the Convertible Loan	101,062	(5,203)
Non-cash interest expense	5,555	3,596
Change in right-of-use asset	516	597
Changes in operating assets and liabilities:
Prepaid expenses and other assets	948	539
Accounts payable and accrued liabilities	(352)	(553)
Accrued compensation	624	(933)
Operating lease liability	(321)	(250)
Net cash used in operating activities	(5,782)	(7,580)
Investing activities:
Purchases of property and equipment	(63)	(99)
Net cash used in investing activities	(63)	(99)
Financing activities:
Proceeds from issuance of term debt, net of issuance costs		10,000
Payments for taxes related to net share settlement of equity awards	(63)	(14)
Proceeds from exercise of stock options	704
Net cash provided by financing activities	641	9,986
Net change in cash, cash equivalents and restricted cash	(5,204)	2,307
Cash, cash equivalents and restricted cash, beginning of period	14,078	14,771
Cash, cash equivalents and restricted cash, end of period	8,874	17,078
Supplemental disclosure of cash flow information:
Debt and Warrant Amendments recorded as debt discount	20,640
Right-of-use asset obtained by assuming operating lease liabilities	$ 11	$ 9